Trial · NCT00717041
Epidemiology of Depression, Anxiety, and Cognitive Impairment
NCT00717041, Completed, University of Rochester; results first posted 2015-06-15
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Epidemiology of Depression, Anxiety, and Cognitive Impairment. Trials, record NCT00717041. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00717041
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Epidemiology of Depression, Anxiety, and Cognitive Impairment
- NCT number
- NCT00717041
- Status
- Completed
- Enrollment
- 1,206 participants, actual
- Lead sponsor
- University of Rochester
- Conditions
- Depression, Anxiety, Cognitive Impairment
- First posted
- 2008-07-16
- Last updated
- 2015-06-15
- Results first posted
- 2015-06-15
- Limitations and caveats
- * Single center, limited generalizability~* Large proportion of individuals lost to follow up~* ED visit may have heightened symptoms~* Validity of instruments in the ED setting is unknown
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Participants With Depression by Patient Health Questionnaire - 9 | 2 hours | Number of participants with depression as measured by the Patient Health Questionnaire - 9, with a score of greater than or equal to 10. |
| Primary | Participants With Cognitive Impairment by Six Item Screener | 2 hours | Number of participants with cogintiive impairment as measured by the Six Item Screener, with greater than 2 questions incorrect |
| Primary | Participants With Anxiety by Generalized Anxiety Disorder - 7 | 2 hours | Participants with anxiety as measured by the Generalized Anxiety Disorder - 7, with a score greater than or equal to 10. |
| Secondary | Depression and Cognitive Impairment at 2 Weeks | 2 weeks | For the individuals who are able to be contacted in 2 weeks, how many still test positive for depression and cognitive impairment. |
Source ClinicalTrials.gov
Outcomes4
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Participants With Depression by Patient Health Questionnaire - 9 | 2 hours | participants | NUMBER | |
| PRIMARY | Participants With Cognitive Impairment by Six Item Screener | 2 hours | participants | NUMBER | |
| PRIMARY | Participants With Anxiety by Generalized Anxiety Disorder - 7 | 2 hours | participants | NUMBER | |
| SECONDARY | Depression and Cognitive Impairment at 2 Weeks | 2 weeks | participants | NUMBER |
Source ClinicalTrials.gov
Results by group5
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Participants With Depression by Patient Health Questionnaire - 9 | Presenting to the ED | 177 | participants | ||
| Participants With Cognitive Impairment by Six Item Screener | Presenting to the ED | 106 | participants | ||
| Participants With Anxiety by Generalized Anxiety Disorder - 7 | Presenting to the ED | 119 | participants | ||
| Depression and Cognitive Impairment at 2 Weeks | Depressed in the ED | 27 | 95% Confidence Interval 19 to 38 | participants | |
| Depression and Cognitive Impairment at 2 Weeks | Cognitively Impaired in the ED | 5 | 95% Confidence Interval 4 to 25 | participants |
Source ClinicalTrials.gov
Participant flow3
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Presenting to the ED | 1,206 | |
| Overall Study | COMPLETED | Presenting to the ED | 1,206 | |
| Overall Study | NOT COMPLETED | Presenting to the ED | 0 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals3
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Presenting to the ED | ||
| Total, other adverse events | Presenting to the ED | 0 | 1,206 |
| Total, serious adverse events | Presenting to the ED | 0 | 1,206 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons1
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison |
|---|
| Depressed in the ED vs Cognitively Impaired in the ED: Depression and Cognitive Impairment at 2 Weeks |
Source Trial comparisons
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00717041
GET https://conductscience.org/api/trials/v1/NCT00717041/registered